Brad Grimes

Tom Lazenby interviews Brad Grimes, Founder and CEO of Clinexion, about device provisioning for decentralised trials and why the device itself is the easy part.

They discuss why buying your own trial devices trades flexibility for sunk cost and the pay-per-use alternative, why “everyone has a phone” is a myth that quietly writes an exclusion criterion into your protocol, and how connectivity — not the device — is where decentralised trials most often break.

Brad explains why it is never if a project will change but when, the downstream costs that hide behind two innocent words (“pass-through cost”), and how device provisioning quietly turns a clinical project manager into a customs, security, and logistics expert.

Drawing on eighteen years in clinical research — from recruitment and EDC to building global device supply chains during Operation Warp Speed — Brad shares the practical realities of getting devices to sites and patients across dozens of countries, why good device management means you stop thinking about it, and how to take the risk, and the hidden cost, off your desk.